15th World Bispecific Summit 2024
Evvnt Promotion / evvnt
Archiv
03.09.2024 - 05.09.2024 The Royal Sonesta Boston, 40 Edwin H Land Boulevard, 02142 Cambridge, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Kongressthemen
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, highlighting biopharma’s continued investment within bispecific therapeutics.
As of 2023, more than 10 bispecific antibodies have been successfully approved by the FDA, and more than 100 are currently in clinical trials, highlighting biopharma’s continued investment within bispecific therapeutics.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
URLs:
Brochure: https://go.evvnt.com/2403858-3?pid=4832
Twitter: https://go.evvnt.com/2403858-4?pid=4832
LinkedIn: https://go.evvnt.com/2403858-5?pid=4832
URLs:
Brochure: https://go.evvnt.com/2403858-3?pid=4832
Twitter: https://go.evvnt.com/2403858-4?pid=4832
LinkedIn: https://go.evvnt.com/2403858-5?pid=4832
Anfragen und Anmeldung:
https://go.evvnt.com/2403858-2?pid=4832
Frau Abigail Cox
Onkologie
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
